Bio-Techne Corp.
TECH
Key stats
- Open
- 72.82
- Day high
- 72.86
- Day low
- 72.80
- Previous close
- 72.80
- Volume
- 2.18M
- VWAP
- 72.83
- 52-week high
- 72.88
- 52-week low
- 43.20
- Market cap
- 11.44B
- Shares out
- 157.06M
- Employees
- 3,000
- Listed
- 1989
About Bio-Techne Corp.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · MINNEAPOLIS, MN · bio-techne.com
Options · expiring Nov 20
Nov 12, 3:59 PM ET- Call open interest
- 120
- Put open interest
- 8
- Put/call
- 0.07
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 75 call | 0.05 | Nov 11, 10:38 AM | 4 | 117 | — |
| 70 call | 1.82 | Oct 8, 12:54 PM | 2 | 2 | — |
| 60 put | 0.05 | Nov 2, 3:56 PM | 2 | 2 | — |
| 85 put | 12.30 | Nov 10, 2:26 PM | 2 | 3 | 61.0% |
| 80 call | 0.04 | Oct 27, 10:22 AM | 1 | 1 | — |
| 70 put | 0.05 | Nov 6, 2:17 PM | 1 | 1 | 56.1% |
Quarterly results
Massive · Nov 6, 2026| Q1 2027 to Sep 30, 2026 | Q4 2026 to Jun 30, 2026 | Q3 2026 to Mar 31, 2026 | Q2 2026 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $299.71M | $321.19M | $311.42M | $295.88M |
| Gross profit | $196.62M | $211.39M | $208.29M | $191.28M |
| Operating income | $36.60M | $74.28M | $75.50M | $54.46M |
| Net income | $28.29M | $54.62M | $51.05M | $38.01M |
| Diluted EPS | 0.18 | 0.35 | 0.32 | 0.24 |
| Operating cash flow | $73.11M | $95.42M | $86.66M | $82.41M |
| Assets | $2.64B | $2.59B | $2.55B | $2.52B |
| Liabilities | $471.13M | $478.50M | $465.30M | $511.71M |
| Equity | $2.17B | $2.11B | $2.09B | $2.01B |
Technicals
Massive · Nov 12, 2026- 50-day average72.53
- 200-day average63.34
- RSI (14 days)62.5
Short interest
Massive · Oct 30, 2026- Oct 30, 20267.70M shares · 2.7 days to cover
- Oct 15, 20267.55M shares · 2.9 days to cover
- Sep 30, 20267.39M shares · 2.1 days to cover
- Sep 15, 20266.63M shares · 2.7 days to cover
Dividends
Massive · Nov 13, 2026- Ex Nov 13, 2026, paid Nov 23, 20260.0800 · 4 a year
- Ex Aug 24, 2026, paid Sep 4, 20260.0800 · 4 a year
- Ex May 18, 2026, paid May 29, 20260.0800 · 4 a year
- Ex Feb 13, 2026, paid Feb 27, 20260.0800 · 4 a year
- Ex Nov 17, 2025, paid Nov 28, 20250.0800 · 4 a year
- Ex Aug 18, 2025, paid Aug 29, 20250.0800 · 4 a year
- Ex May 19, 2025, paid May 30, 20250.0800 · 4 a year
- Ex Feb 14, 2025, paid Feb 28, 20250.0800 · 4 a year
Splits
Massive · Nov 30, 2022- Nov 30, 20224-for-1
Related companies
MassiveNews coverage
No stories about Bio-Techne Corp. right now.